Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

Inclusion Criteria

• •1. Written informed consent and HIPAA authorization for release of personal health information. NOTE: HIPAA authorization may be included in the informed consent or obtained separately.
• •2. Age ≥ 18 years at the time of consent
• •3. Female
• •4. Histological or cytological confirmation of invasive breast cancer.
• •5. Planned to undergo adjuvant or neoadjuvant chemotherapy treatment for invasive breast cancer AND pegfilgrastim (or biosimilar substitution) treatment for neutropenic prophylaxis.
• •6. Ability to read and understand the English and/or Spanish language
• •7. As determined by the enrolling physician, ability of the subject to understand and comply with study procedures for the entire length of the study